Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith transcript of our Conference Call which was held on Tuesday, 25th April, 2023 to discuss our acquisition of 33.38% shareholding in Unichem Laboratories Ltd.
We are enclosing herewith transcript of our Conference Call which was held on Thursday, 16th February, 2023 to discuss the Company's Q3FY23 earnings and business update.
We are enclosing herewith transcript of our Conference Call which was held on Monday, 14th November, 2022 to discuss the Company's Q2FY23 earnings and business update.
We are enclosing herewith transcript of our Conference Call which was held on Thursday, 11th August, 2022 to discuss the Company's Q1FY23 earnings and business update.
We are enclosing herewith transcript of our Conference Call which was held on Wednesday, 25th May, 2022 to discuss the Company's Q4FY22 earnings and business update.
We are enclosing herewith transcript *of our Conference Call which was held on Tuesday, 15th February, 2022 to discuss the Company''s Q3FY22 earnings and business update.
